ZAI LAB LIMITED Accounts Payable
ZAI LAB LIMITED (ZLAB) had Accounts Payable of $136.69 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-06
- 2026-06-30: Accounts Payable, Current $136.69M.
- 2026-03-31: Accounts Payable, Current $126.17M.
- 2025-12-31: Accounts Payable, Current $141.61M.
- 2025-09-30: Accounts Payable, Current $99.71M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $136.69M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $126.17M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $141.61M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $99.71M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $107.36M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $103.02M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $100.91M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $120.65M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $127.34M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $88.12M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $112.99M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $55.02M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $67.03M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $66.36M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $65.97M 10-K · filed 2024-02-27 | |
| 2022-09-30 | $90.11M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $108.44M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $98.16M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $126.16M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $51.41M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $125.62M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $41.41M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $62.64M 10-K · filed 2022-03-01 | |
| 2020-06-30 | $32.39M 6-K · filed 2020-09-11 | |
| 2019-12-31 | $22.66M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $20.46M 6-K · filed 2020-01-21 | |
| 2018-12-31 | $37.43M 20-F · filed 2020-04-29 | $37.43M 20-F · filed 2019-03-29 |
| 2017-12-31 | $8.97M 20-F · filed 2019-03-29 | |
| 2016-12-31 | $523.34K 20-F · filed 2018-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |